BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Obesity
,
Endothelial cell
,
Pharmacogenetics
,
Lipitor
,
rs2476601
,
SNCA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
TAR
Summary
General Info
Curated Studies
Most Correlated Studies
Peripheral airway epithelial cells from smoker lungs and healthy lungs of lung cancer patients
Effect of tobacco condensate exposure on human bronchial epithelial cells
Tobacco smoke condensate treated A549 and Calu-6 lung cancer cell lines
L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)
FE1 lung epithelial cells after 6hr exposure to sub-toxic doses of coal tar
Explore Curated Studies Results
Literature
Most Relevant Literature
Aqueous cigarette tar extracts disrupt corticogenesis from human embryonic stem cells in vitro.
Infrared Spectroscopy for Online Measurement of Tars, Water, and Permanent Gases in Biomass Gasifica…
Investigation into the risk of ultra-low tar cigarettes and lung cancer.
Tar, nicotine and carbon monoxide yield of UK cigarettes and the risk of non-muscle-invasive and mus…
Evaluation of surfactant flushing for remediating EDC-tar contamination.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety and Tolerability of TAR-302-5018 in Subjects With Idiopathic Overactive Bladder
Safety and Tolerability of TAR-200 mg in Subjects With Non-Muscle-Invasive Bladder Cancer
Safety and Tolerability of TAR-302-5018 in Subjects With Neurogenic Detrusor Overactivity Resulting …
Safety and Tolerability of TAR-200 and Nivolumab in Subjects With Muscle-Invasive Bladder Cancer
A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calm…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ